On this episode we talk about Tony’s recent journal entries regarding ADH, WSA and SFR, then we answer your questions about why we might invest in companies with poor financial health scores on Stock Doctor; why Tony isn’t a “range trader”; how Tony would start a new fund with only $10K; whether or not we should wait until reporting season before investing; definitions of “positive sentiment”; and the current takeover of IFN.
We start off this episode with a recap of last week’s journal entries, then answer your questions about when Tony sells a stock, how to build a portfolio from scratch, the pros and cons of different Buy and Sell order types, and which stocks are in Tony’s portfolio.
Our guest today is Johannes Risseeuw, Executive Chairman of Damstra (DTC). He talks to us about what Damstra does, what the role of an Executive Chairman involves, the capital raising process, and what Tony was like 20 years ago when they worked together at Shell.
We talk about the thinking behind some of Tony’s recent journal entries, including Eclipx (ECX), AGL, Credit Corp (CCP) and Sandfire Resources (SFR). Then we get into answering questions. Elmar asks about Michael Hill International (MHJ) and how to mathematically find out at what point the selected stock is no longer a buy. Chris asks whether or not we can use a moving average to replace the three-point trend line. Dr J asks how Tony decides when to sell a stock.
On this Q&A episode, TK answers questions about whether stocks that have been bought in an Up trend perform better than those bought after a break out from a Down Trend, about the relative importance of market depth for LYL, whether or not profit taking makes any sense, how he uses the the 52 week high AFR list, HUG lines, the three point trend line for ANZ, and the logic of selling AGD.
Stephen Mayne is one of Australia’s best known and most feared shareholder activists. He’s also the founder of Crikey, a writer for InvestSmart and claims to own the world’s biggest small share portfolio: 500 holdings worth less than $30,000. He came on today to chat about capital raisings and shareholder activism.